70-Fold Price Increase Puts Drug at $89,000

Marathon Pharmaceuticals will charge $89,000 annually in the U.S. for a decades-old steroidal drug that was approved for U.S. sale for the first time on Thursday, a price that is as much as 70 times higher than the drug ’s price overseas.

Source: WSJ.com: Health - February 11, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news